Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer

Clinical trial NCT06584032 · RECRUITING

Trial details

NCT number: NCT06584032
Sponsor: Hutchmed
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Endometrial Cancer

Start date: 2024-12-12
Primary completion: 2029-01-08
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.